RPL30
Large ribosomal subunit protein eL30
Also known as: L30, RL30_HUMAN
Cross-references: UniProt · Ensembl · Human Protein Atlas · GeneCards · NCBI Gene
Protein identityUniProt · HPA
- UniProt accession
- P62888
- Gene
- RPL30
- Ensembl
- ENSG00000156482
- Chromosome
- 8
- Canonical length
- 115 aa
- Protein class
- Plasma proteins, Predicted intracellular proteins, Ribosomal proteins
- Subcellular location
- Endoplasmic reticulum,Cytosol
OverviewNCBI Gene
Ribosomes, the organelles that catalyze protein synthesis, consist of a small 40S subunit and a large 60S subunit. Together these subunits are composed of 4 RNA species and approximately 80 structurally distinct proteins. This gene encodes a ribosomal protein that is a component of the 60S subunit. The protein belongs to the L30E family of ribosomal proteins. It is located in the cytoplasm. This gene is co-transcribed with the U72 small nucleolar RNA gene, which is located in its fourth intron. As is typical for genes encoding ribosomal proteins, there are multiple processed pseudogenes of this gene dispersed through the genome. [provided by RefSeq, Jul 2008]
Canonical amino-acid sequenceUniProt
115 residues, UniProt reviewed canonical sequence.
>P62888|RPL30
1 MVAAKKTKKS LESINSRLQL VMKSGKYVLG YKQTLKMIRQ GKAKLVILAN NCPALRKSEI
61 EYYAMLAKTG VHHYSGNNIE LGTACGKYYR VCTLAIIDPG DSDIIRSMPE QTGEKLocalizationUniProt · AlphaFold · HPA
Whether an antibody against RPL30 can act on the native protein depends on physical access: surface and secreted proteins are reachable by circulating antibodies, intracellular proteins usually are not.
- Antibody reachability
- Intracellular
- Secreted
- No
- Transmembrane segments
- 0
- Mean surface accessibility (rSASA)
- 0.34
- Highest tissue expression
- 5,328 nTPM
Expression across tissuesHPA
Tissue
- ovary: 5,328 nTPM
- breast: 3,806 nTPM
- tonsil: 3,642 nTPM
- bone marrow: 3,549 nTPM
- skin: 3,165 nTPM
- lymph node: 3,080 nTPM
Single-cell type
- ovarian stromal cells: 6,048 nCPM
- esophageal suprabasal cells: 5,933 nCPM
- esophageal basal cells: 5,464 nCPM
- breast myoepithelial cells: 5,391 nCPM
- fallopian secretory cells: 5,375 nCPM
- extravillous trophoblasts: 4,877 nCPM
Immune cell
- total PBMC: 4,647 nTPM
- naive CD4 T-cell: 4,486 nTPM
- naive CD8 T-cell: 3,699 nTPM
- memory B-cell: 3,548 nTPM
- memory CD4 T-cell: 3,494 nTPM
- naive B-cell: 3,237 nTPM
Brain region
- white matter: 680 nTPM
- medulla oblongata: 615 nTPM
- spinal cord: 614 nTPM
- basal ganglia: 594 nTPM
- hypothalamus: 566 nTPM
- thalamus: 515 nTPM
Genetic constraint and essentialitygnomAD · DepMap
Does the body need this protein intact? Low LOEUF or a strong DepMap dependency means loss or blockade of the protein is likely to be felt.
- gnomAD LOEUF (loss-of-function intolerance)
- 0.49
- gnomAD pLI
- 0.85
- gnomAD missense Z
- 1.99
- DepMap mean gene effect
- -1.73
- DepMap dependency class
- pan
Cancer expressionTCGA
Across TCGA tumor cohorts, this protein is over-expressed in roughly 12% of surveyed tumor types (aggregate summary; per-cohort expression, alteration, and survival load in the interactive view).
OntologyGO
Biological processes
- antimicrobial humoral immune response mediated by antimicrobial peptide
- cytoplasmic translation
- defense response to Gram-negative bacterium
- killing of cells of another organism
- translation
Molecular functions
Cellular components
Protein domainsUniProt · Pfam · InterPro
- Ribosomal protein eL8/eL30/eS12/Gadd45
- Ribosomal protein eL30-like superfamily
- Ribosomal protein L7Ae/L30e/S12e/Gadd45 family
- Large ribosomal subunit protein eL30
- Large ribosomal subunit protein eL30, conserved site
- Large ribosomal subunit protein eL30-like
KeywordsUniProt
InteractionsUniProt · HPA
Protein binding partners of RPL30 in the human serome: UniProt-annotated complex subunits plus reported interactors. Each links to its own Seroatlas record.
Antibody and autoantibody relevanceSeroatlas analysis
Seroatlas reads RPL30 as an antibody target. Whether an autoantibody or antibody against RPL30 could matter depends on whether native RPL30 is physically reachable, whether the body needs it intact, and whether it acts in a disease-relevant tissue.
RPL30 is annotated as predominantly intracellular. Intracellular proteins are common autoantibody markers, becoming visible to the immune system after cell injury or altered processing, but are usually markers of disease rather than direct drivers.
Annotation status
The present source text does not explicitly label RPL30 as an autoantigen. Seroatlas presents hypothesis context only and does not manufacture a known-serology claim.
Loading the interactive Seroatlas protein explorer...